Telemetry Investments, L.L.C. Rapt Therapeutics, Inc. Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
A detailed history of Telemetry Investments, L.L.C. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 12,000 shares of RAPT stock, worth $22,440. This represents 0.38% of its overall portfolio holdings.
Number of Shares
12,000Holding current value
$22,440% of portfolio
0.38%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
125Shares Held
29.1MCall Options Held
905KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$5.81 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$5.01 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$4.56 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$3.23 Million0.61% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$2.99 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $55.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...